Quiet essentials · Free shipping over $75 · Shop the edit

Doramapimod Pembrolizumab used in cancer immunotherapy

SKU: 3686756049

4.4
USD173.00 USD201.00

Pay in 4 interest-free payments of $43.25 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

used in cancer immunotherapy

The expression of IL-36 cytokines occurs mainly in the lung and skin and can be derived from diverse epithelial cell types including keratinocytes

WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2

ZBP1 is highly expressed in lymphatic tissues including lymph node

bone marrow and spleen

Doramapimod Pembrolizumab used in cancer immunotherapyDoramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38=38 nM, for p38=65 nM, for p38=200 nM, and for p38=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0. 1 nM). Doramapimod also inhibits B Raf with an IC50 of 83 nM.

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products